Elan tells advisors to assess all strategic interests


Elan (ELN) said its board, in response to several unsolicited corporate enquiries, has instructed its advisors to assess any and all strategic interests in the company that reflect the intrinsic value of the totality of Elan's business platform. Both the board and executive management are aligned in exploring all opportunities that maximize the full value of the company for its shareholders, the company said. The board added that it "strongly endorses and recommends that the Elan shareholders vote in favor of the four transactions, namely Theravance (THRX), AOP, D0005/Speranza, and $200M share repurchase, being voted on at the Elan's meeting on June 17.

View Comments (0)